Search filters

List of works by Tamas Hickish

A meta-analysis of prevalence rates and moderating factors for cancer-related post-traumatic stress disorder

scientific article published on 22 August 2014

A midline for oxaliplatin infusion: the myth of safety devices

scientific article

A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab ⬇️

scientific article published on March 15, 2012

A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancer ⬇️

scientific article published on June 1, 1998

Clinical benefit from palliative chemotherapy in non-small-cell lung cancer extends to the elderly and those with poor prognostic factors ⬇️

scientific article published on July 1, 1998

Comparing cancer mortality and GDP health expenditure in England and Wales with other major developed countries from 1979 to 2006 ⬇️

scientific article published on October 4, 2011

Continuous infusional topotecan in advanced breast and non-small-cell lung cancer: no evidence of increased efficacy ⬇️

scientific article published on January 1, 1997

Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3

scientific article

Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial

scientific article published on 11 May 2015

Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial

scientific article published on 19 June 2014

Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesothelioma ⬇️

scientific article published on March 1, 1998

Interactions in the aetiology, presentation and management of synchronous and metachronous adenocarcinoma of the prostate and rectum ⬇️

scientific article published on October 1, 2012

Interleukin-1 receptor antagonist levels predict favorable outcome after bermekimab, a first-in-class true human interleukin-1α antibody, in a phase III randomized study of advanced colorectal cancer

scientific article published on 12 December 2018

Management of colorectal cancer and diabetes.

scientific article published on 13 December 2013

Metabolism, excretion and pharmacokinetics of a single dose of [ 14 C]-raltitrexed in cancer patients ⬇️

scientific article published on January 1, 1998

Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA) ⬇️

scientific article published on May 22, 2013

Pre-treatment endogenous interleukin-1 receptor antagonist (IL-1Ra) levels in metastatic colorectal cancer (mCRC) patients are associated with clinical outcomes after anti-interleukin-1a therapy (MABp1)

scientific article published on 01 June 2017

Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer

scientific article

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial

scientific article published in May 2014

Tamoxifen Therapy and Carcinogenic Risk ⬇️

scientific article published on September 20, 1995

Paulina is supported by:

About Paulina

Help